226 related articles for article (PubMed ID: 8371711)
21. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.
Gebremedhin D; Lange AR; Campbell WB; Hillard CJ; Harder DR
Am J Physiol; 1999 Jun; 276(6):H2085-93. PubMed ID: 10362691
[TBL] [Abstract][Full Text] [Related]
22. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.
Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L
Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849
[TBL] [Abstract][Full Text] [Related]
23. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
24. Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors.
Ishii I; Chun J
Neuroreport; 2002 Apr; 13(5):593-6. PubMed ID: 11973452
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism.
Caulfield MP; Brown DA
Br J Pharmacol; 1992 Jun; 106(2):231-2. PubMed ID: 1327374
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
28. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
29. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
[TBL] [Abstract][Full Text] [Related]
30. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid ligand-receptor signaling in the mouse uterus.
Das SK; Paria BC; Chakraborty I; Dey SK
Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons.
Nogueron MI; Porgilsson B; Schneider WE; Stucky CL; Hillard CJ
J Neurochem; 2001 Oct; 79(2):371-81. PubMed ID: 11677265
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Breivogel CS; Griffin G; Di Marzo V; Martin BR
Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
[TBL] [Abstract][Full Text] [Related]
34. Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP.
Akinshola BE; Taylor RE; Ogunseitan AB; Onaivi ES
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):242-8. PubMed ID: 10543424
[TBL] [Abstract][Full Text] [Related]
35. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
De Petrocellis L; Melck D; Palmisano A; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8375-80. PubMed ID: 9653194
[TBL] [Abstract][Full Text] [Related]
36. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells.
Basavarajappa BS; Hungund BL
J Neurochem; 1999 Feb; 72(2):522-8. PubMed ID: 9930723
[TBL] [Abstract][Full Text] [Related]
37. Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides.
Barg J; Fride E; Hanus L; Levy R; Matus-Leibovitch N; Heldman E; Bayewitch M; Mechoulam R; Vogel Z
Eur J Pharmacol; 1995 Dec; 287(2):145-52. PubMed ID: 8749028
[TBL] [Abstract][Full Text] [Related]
38. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling.
Bayewitch M; Avidor-Reiss T; Levy R; Barg J; Mechoulam R; Vogel Z
FEBS Lett; 1995 Nov; 375(1-2):143-7. PubMed ID: 7498464
[TBL] [Abstract][Full Text] [Related]
39. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
40. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]